Product Images Repatha

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 86 images provide visual information about the product associated with Repatha NDC 55513-750 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

repatha 01

repatha 01

This is a table that shows the number of participants at risk over a period of 36 months for a clinical trial that compares the drug Repatha with a placebo for a certain condition. The table shows the number of participants at risk every six months for three years. The first row shows the time in months and the second row shows the number of participants at risk for each treatment group.*

Figure 1. Estimated Cumulative Incidence of Primary Composite Endpoint Over 3 Years in FOURIER - repatha 02

Figure 1. Estimated Cumulative Incidence of Primary Composite Endpoint Over 3 Years in FOURIER - repatha 02

This appears to be a table of data, showing the number of individuals at risk for a placebo group and a group taking a medication called Repatha over a span of 55 months. The table also shows the number of individuals at each time point for both groups.*

Figure 2. Estimated Cumulative Incidence of Key Secondary Composite Endpoint Over 3 Years in FOURIER - repatha 03

Figure 2. Estimated Cumulative Incidence of Key Secondary Composite Endpoint Over 3 Years in FOURIER - repatha 03

Figure 3. Effect of REPATHA on LDL C in Patients with Hyperlipidemia when Combined with Statins (Mean % Change from Baseline to Week 12 in LAPLACE 2) - repatha 04

Figure 3. Effect of REPATHA on LDL C in Patients with Hyperlipidemia when Combined with Statins (Mean % Change from Baseline to Week 12 in LAPLACE 2) - repatha 04

This text appears to be depicting data in a table format comparing the percent change from a baseline over the course of several weeks for two different treatments, Placebo once monthly and REPATHA 420 mg once monthly. It includes the number of observed participants for each week of the study.*

Figure 4. Effect of REPATHA 420 mg Once Monthly on LDL C in Patients with Hyperlipidemia in DESCARTES - repatha 05

Figure 4. Effect of REPATHA 420 mg Once Monthly on LDL C in Patients with Hyperlipidemia in DESCARTES - repatha 05

Figure 5. Effect of REPATHA on LDL C in Patients with HeFH (Mean % Change from Baseline to Week 12 in RUTHERFORD 2) - repatha 06

Figure 5. Effect of REPATHA on LDL C in Patients with HeFH (Mean % Change from Baseline to Week 12 in RUTHERFORD 2) - repatha 06

This is a description of the design of a study or clinical trial. It includes information about the number of subjects involved in the study, the baseline week, and the study week. It appears that there were two groups in the study, one group received a placebo and the other group received a drug called EvoMab at a dosage of 420 mg QM.*

repatha 07

repatha 07

This is a description of a medicine cartridge with a white plunger, labeled with the name of the medicine. The text instructs the user not to rotate the plunger. No further information is available.*

Prefilled Cartridge - repatha 08

Prefilled Cartridge - repatha 08

The text describes the parts and instructions for using a medical device. It includes a cartridge door that should not be closed without a cartridge, a skin status start button, an adhesive light that should not be pressed until ready to inject, a medicine window, and pull tabs. The purpose of the medical device is not specified.*

On Body Infusor - repatha 09

On Body Infusor - repatha 09

This text is describing a needle cover that is made of adhesive paper. There is also a battery needle inside the strip, which is located under the cover. The cover has both left and right pull tabs.*

Open the on body infusor by swinging the cartridge door to the right. Then, leave the door open. Do not close the cartridge door before the cartridge is loaded. - repatha 10

Open the on body infusor by swinging the cartridge door to the right. Then, leave the door open. Do not close the cartridge door before the cartridge is loaded. - repatha 10

The text seems to describe a medical device called "On-body infusor" that uses a "prefilled T plastic cover cartridge" to administer medication. It also mentions a "clear tray" that may be used to hold the device or accessories.*

Inspect the cartridge. - repatha 11

Inspect the cartridge. - repatha 11

Clean the cartridge bottom. - repatha 12

Clean the cartridge bottom. - repatha 12

This is a list of body parts - Upper arm, Stomach area (abdomen), and Thigh.*

Loadcartridgestraight - repatha 13

Loadcartridgestraight - repatha 13

Press downfirmly - repatha 14

Press downfirmly - repatha 14

Swing the door to the left. Then, squeeze firmly until it snaps shut. Apply enough pressure when closing the door and make sure there is a “snap” before going to the next step. - repatha 15

Swing the door to the left. Then, squeeze firmly until it snaps shut. Apply enough pressure when closing the door and make sure there is a “snap” before going to the next step. - repatha 15

Peel away both green pull tabs to show the adhesive. The on body infusor is on when the blue status light flashes. - repatha 16

Peel away both green pull tabs to show the adhesive. The on body infusor is on when the blue status light flashes. - repatha 16

This appears to be instructions for using a cartridge that needs to be loaded and then injected within 5 minutes of loading. The text instructs the user to press down firmly after loading the cartridge. No additional context or product details are available.*

Stomach area placement - repatha 17

Stomach area placement - repatha 17

Thigh placement - repatha 18

Thigh placement - repatha 18

This document does not provide enough information to generate a useful description. Please provide a different document.*

When the blue light flashes, the on body infusor is ready. Keep the stretch (stomach area method only). Hold the loaded on body infusor with the blue light visible, and place it on your skin. You may hear beeps. - repatha 19

When the blue light flashes, the on body infusor is ready. Keep the stretch (stomach area method only). Hold the loaded on body infusor with the blue light visible, and place it on your skin. You may hear beeps. - repatha 19

What do I do if the loaded on body infusor status light continuously flashes red and I hear beeps - repatha 20

What do I do if the loaded on body infusor status light continuously flashes red and I hear beeps - repatha 20

Flashing warning light - repatha 21

Flashing warning light - repatha 21

beep-beep-beep-beep- beep - repatha 22

beep-beep-beep-beep- beep - repatha 22

repatha 23

repatha 23

It is not possible to generate a useful description with the given text as it consists of just a sound description with no context.*

Do not re-use - repatha 24

Do not re-use - repatha 24

Serial number - repatha 25

Serial number - repatha 25

Type BF Applied Part - repatha 26

Type BF Applied Part - repatha 26

Do not use if packaging is damaged - repatha 27

Do not use if packaging is damaged - repatha 27

On-Body Infusor containing420 mg/ 3.5 mL (120 mg/mL) - repatha 28

On-Body Infusor containing420 mg/ 3.5 mL (120 mg/mL) - repatha 28

Sterilized using ethylene oxide - repatha 29

Sterilized using ethylene oxide - repatha 29

Wait at least 30 minutes for the autoinjector to reach room temperature before injecting - repatha 30

Wait at least 30 minutes for the autoinjector to reach room temperature before injecting - repatha 30

Inspect the Repatha SureClick autoinjector. - repatha 31

Inspect the Repatha SureClick autoinjector. - repatha 31

New autoinjector, Alcohol wipes, Cotton ball or gauze pad, Adhesive bandage, Sharps disposal container (see Step 4: Finish) - repatha 32

New autoinjector, Alcohol wipes, Cotton ball or gauze pad, Adhesive bandage, Sharps disposal container (see Step 4:  Finish) - repatha 32

Prepare and clean your injection site. - repatha 33

Prepare and clean your injection site. - repatha 33

Pull the orange cap off only when you are ready to inject. - repatha 34

Pull the orange cap off only when you are ready to inject. - repatha 34

Do not leave the orange cap off for more than five minutes. This can dry out the medicine. - repatha 35

Do not leave the orange cap off for more than five minutes.  This can dry out the medicine. - repatha 35

Thigh:Stretch method - repatha 36

Thigh:Stretch method - repatha 36

Stomach or upper arm:Pinch method - repatha 37

Stomach or upper arm:Pinch method - repatha 37

Hold the stretch or pinched skin. With the orange cap off, place autoinjector on the skin at 90 degrees. Do not touch the gray start button yet. - repatha 38

Hold the stretch or pinched skin. With the orange cap off, place autoinjector on the skin at 90 degrees. Do not touch the gray start button yet. - repatha 38

Firmly push down the autoinjector onto the skin until it stops moving. - repatha 39

Firmly push down the autoinjector onto the skin until it stops moving. - repatha 39

Before use, guide to parts - repatha 40

Before use, guide to parts - repatha 40

Guide to parts- after use - repatha 41

Guide to parts- after use - repatha 41

Remove the Repatha prefilled syringe carton from the refrigerator and wait 30 minutes. - repatha 42

Remove the Repatha prefilled syringe carton from the refrigerator and wait 30 minutes. - repatha 42

This appears to be a description of a medicine container, with a gray start button, an expiration date, a window, and an orange cap. There is also a yellow safety guard, which seems to indicate that there is a needle inside. The text "0000000 00/14" may be a batch or lot number and expiration date.*

1 Rapatha prefilled syringe - repatha 43

1 Rapatha prefilled syringe - repatha 43

This appears to be a partial label of a medical syringe. It shows a yellow window indicating the completion of an injection with a corresponding expiration date. It also displays a yellow safety guard to cover the needle and an orange cap that should be removed before use.*

Choose your injection site. - repatha 44

Choose your injection site. - repatha 44

Clean your injection site with an alcohol wipe. Let your skin dry before injecting - repatha 45

Clean your injection site with an alcohol wipe. Let your skin dry before injecting - repatha 45

Remove prefilled syringe from tray. - repatha 46

Remove prefilled syringe from tray. - repatha 46

Check the medicine and syringe. - repatha 47

Check the medicine and syringe. - repatha 47

This is a simple list of body parts: the upper arm, stomach, and thigh.*

Carefully pull the gray needle cap straight out and away from your body. - repatha 48

Carefully pull the gray needle cap straight out and away from your body. - repatha 48

Place the cap in the sharpsdisposal container right away. - repatha 49

Place the cap in the sharpsdisposal container right away. - repatha 49

PRINCIPAL DISPLAY PANEL1 x 1 mL Prefilled SyringeNDC 55513-750-01Amgen®RepathaTM (evolocumab)Injection140 mg/mL140 mg/mLPrefilled SyringeFor Subcutaneous Use OnlyStore at 2°C to 8°C (36°F to 46°F). Do NotFreeze or Shake.Store in Carton to Protect from Light.(see side panel for additional storage information)Sterile Solution – No PreservativeSingle UseCAUTION, See package insert for full prescribing information and Instructions for UseThis Product Contains Dry Natural Rubber.Keep out of the sight and reach of childrenRx Only - repatha 50

PRINCIPAL DISPLAY PANEL1 x 1 mL Prefilled SyringeNDC 55513-750-01Amgen®RepathaTM (evolocumab)Injection140 mg/mL140 mg/mLPrefilled SyringeFor Subcutaneous Use OnlyStore at 2°C to 8°C (36°F to 46°F).  Do NotFreeze or Shake.Store in Carton to Protect from Light.(see side panel for additional storage information)Sterile Solution – No PreservativeSingle UseCAUTION, See package insert for full prescribing information and Instructions for UseThis Product Contains Dry Natural Rubber.Keep out of the sight and reach of childrenRx Only - repatha 50

PRINCIPAL DISPLAY PANEL1 x 3.5 mL Prefilled Cartridge1 On-Body InfusorNDC 55513-770-01Amgen®Repatha® Pushtronex™ system(evolocumab)On-Body Infusor and Prefilled Cartridge420mg/3.5mL420mg/3.5mLFor Subcutaneous Use OnlySingle-Use OnlySterile Solution – No PreservativeStore refrigerated at 2°C to 8°C (36°F to 46°F). Do Not Freeze or Shake.Store in Carton to Protect from Light.(see side panel for additional storage information)Keep out of the sight and reach of childrenRefer to Instructions for UseDo Not Use if Package is DamagedOn-Body Infusor Sterilized Using Ethylene OxideKeep DrySingle UseType BF Applied PartRelative HumidityRange is 15% to 85%Rx Only - repatha 51

PRINCIPAL DISPLAY PANEL1 x 3.5 mL Prefilled Cartridge1 On-Body InfusorNDC 55513-770-01Amgen®Repatha® Pushtronex™ system(evolocumab)On-Body Infusor and Prefilled Cartridge420mg/3.5mL420mg/3.5mLFor Subcutaneous Use OnlySingle-Use OnlySterile Solution – No PreservativeStore refrigerated at 2°C to 8°C (36°F to 46°F).  Do Not Freeze or Shake.Store in Carton to Protect from Light.(see side panel for additional storage information)Keep out of the sight and reach of childrenRefer to Instructions for UseDo Not Use if Package is DamagedOn-Body Infusor Sterilized Using Ethylene OxideKeep DrySingle UseType BF Applied PartRelative HumidityRange is 15% to 85%Rx Only - repatha 51

repatha 52

repatha 52

The text is readable but it is not enough to provide a useful description. It only mentions the name of a product and a warning about a needle being inside. More context is needed.*

repatha 53

repatha 53

repatha 54

repatha 54

repatha 55

repatha 55

repatha 56

repatha 56

repatha 57

repatha 57

repatha 58

repatha 58

repatha 59

repatha 59

repatha 60

repatha 60

repatha 61

repatha 61

repatha 62

repatha 62

repatha 63

repatha 63

repatha 64

repatha 64

This text is a list of keywords or phrases related to safety equipment or procedures. Specifically, it mentions a yellow safety guard that may contain a needle inside. Without further context or details, it is difficult to determine the specific application or industry for which this equipment is intended.*

repatha 65

repatha 65

repatha 66

repatha 66

repatha 67

repatha 67

repatha 68

repatha 68

repatha 69

repatha 69

This is a list of items related to a medical syringe, including a plunger rod, a syringe barrel, a gray needle, and a needle cap. The text does not provide much context or detail beyond these basic components.*

repatha 70

repatha 70

This is not-available as the text is incomplete and doesn't provide sufficient information to generate a useful description.*

repatha 71

repatha 71

repatha 72

repatha 72

repatha 73

repatha 73

This text provides a list of body parts; upper arm, stomach, and thigh.*

repatha 74

repatha 74

repatha 75

repatha 75

repatha 76

repatha 76

repatha 77

repatha 77

repatha 78

repatha 78

repatha 79

repatha 79

repatha 80

repatha 80

repatha 81

repatha 81

repatha 82

repatha 82

repatha 83

repatha 83

repatha 84

repatha 84

This is a description of a drug called Repatha (evolocumab) which is for subcutaneous use only. It comes in pre-filled autoinjectors of 2x1 mL. The text mentions a sterile solution with no preservatives and indicates caution with package inserts. However, due to the incomplete and fragmented nature of the text obtained by , the overall description is not comprehensive and may not be useful for medical purposes.*

repatha 85

repatha 85

This text appears to be the product information of a medication called Repatha. It comes in a pre-filled syringe with a concentration of 10mg/ml and should be stored between 2-8 degrees Celsius. The medication is intended for subcutaneous use only and instructions are given to protect it from light and to keep it out of reach of children. The text further describes a warning to be cautious when handling the product.*

repatha 86

repatha 86

This description is not available due to the lack of coherent and readable text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.